Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2020 Q2- Text added to 2020 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
ABR, AFFINE, cardiac, carryback, compound, contention, cryopreserved, deficient, depreciation, division, enzyme, evolution, fourth, Gal, GLA, graft, IMD, immune, Importantly, incomplete, Lonza, male, moderate, moderately, morbidity, multicenter, neuropathy, onset, pivotal, preconditioning, predominantly, pretreatment, readout, regimen, renal, secondary, skin, soluble, steady, surgery, tolerogenic
Valuein 2020 Q2 filing- Value in 2020 Q3 filing
Original filings
Filing view